Phase I
Phase II
MIDD
Pharmacometrics
Ophthalmology
Program strategies and efficiencies
PAGE 33 (2025) Abstr 11604
Ooi QX, Yin AY, Krawczyk B, Gliem M, Brown D, Jhaveri C, Gonzalez VH, Wykoff C, Nassar K, Wölke S, Simons G, Wagner M, Sivaprasad S, Nguyen QD, Niebecker R